Delivery Order W81XWH18D0030-W81XWH19F0043

This $16,035 firm-fixed price purchase order was awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a New Jersey-based foreign-owned minority-owned small business. The award is for the acquisition of 2 grams of Minnelide (CAS: 1254702-87-8) and 10 grams of GNE-618 (CAS: 1362151-42-5), which are chemical compounds used to support NCATS' biomedical research programs. MedChemExpress has...

This is a federal contract award to Aapharmasyn LLC, a small disadvantaged business, for Experimental Therapeutics Medicinal Chemistry services. The contract was awarded by the Defense Health Agency, a component of the U.S. Department of Defense, with a ceiling value of $77,780.00. The contract has a firm fixed price pricing type and was awarded as a delivery order under the Experimental Therapeutics Medicinal Chemistry contract vehicle. The contract does not have a set-aside designation. The...

This is a $376,706 firm fixed-price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to MedChemExpress LLC, a small disadvantaged business located in New Jersey. The contract supports the SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT) program, providing chemical compounds and other scientific inputs for the agency's biomedical research initiatives....

Medchemexpress LLC was awarded a firm fixed price purchase order valued at seventy-seven thousand one hundred ninety-three dollars and forty-one cents ($77,193.41) by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to deliver one chemical library of five hundred nine bioactive compounds. The award originated from a sources sought notice issued by the National Institutes of Health's National Center for Advancing Translational...

This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Medchemexpress LLC, a foreign-owned, minority-owned, self-certified small disadvantaged business. The $10,700 contract is for the provision of commercial chemical and drug reagents, with a period of performance ending on July 28, 2026. Medchemexpress is a New Jersey-based company that specializes in supplying chemical compounds, research materials, and scientific synthesis...

The National Institutes of Health's National Center for Advancing Translational Sciences awarded a $2.1 million firm fixed price purchase order to Avista Pharma Solutions, Inc., doing business as Cambrex, for the acquisition of two kilograms of cGMP-grade GS-441524 drug substance with an option for two additional kilograms. The drug substance will support preclinical and Phase I clinical studies by the NIH to evaluate GS-441524's potential as a COVID-19 treatment through assessing its safety,...

This is a federal contract award by the Defense Health Agency (DHA), a defense agency, to Aapharmasyn LLC, a small disadvantaged woman-owned limited liability company. The contract, valued at $82,000.00, is for experimental therapeutics medicinal chemistry services. The contract is a delivery order awarded under the Experimental Therapeutics Medicinal Chemistry master IDIQ contract vehicle. The contract has no set-aside designation. The period of performance for this contract runs through May 1,...

Organix Chemistry Solutions LLC was awarded a $3.677 million delivery order against the Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences' CRO Support for NCATS Medicinal Chemistry for Lead Optimization master IDIQ contract. The delivery order, issued for the period of September 28, 2020 through September 27, 2022, provides synthetic chemistry support services to the TDB Medicinal Chemistry Team. Key services will involve...

The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health (NIH) awarded a $30,035 firm fixed price purchase order to Medchemexpress LLC of Princeton, New Jersey for the synthesis of synthetic compounds to support NCATS. Under the terms of the award, Medchemexpress will provide synthetic compound synthesis services to NCATS by November 11, 2022. No set-aside provisions were applied to this procurement. As the lead institute for NIH's translational...

This is a delivery order contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Alchem Laboratories Corporation, a for-profit manufacturer located in Alachua, Florida. The $3,171,368 cost-plus-fixed-fee contract, which has no set-aside designation, is for the synthesis of up to ten non-GMP (non-Good Manufacturing Practice) small molecule samples per year for the NCI's Program 66C, with a period of performance through...